首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1945380

2026年全球注射給藥裝置市場報告

Injectable Drug Delivery Devices Global Market Report 2026

出版日期: 2026年02月11日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，注射給藥裝置的市場規模顯著成長，預計將從2025年的543億美元成長到2026年的586.9億美元，複合年成長率為8.1%。過去幾年的成長可歸因於多種因素，例如慢性病盛行率的上升、生物製藥和生物相似藥的推廣、醫院注射治療的增加、無菌生產過程的改進以及注射裝置的日益普及。

預計未來幾年注射給藥裝置市場將穩定成長。慢性病是指持續超過三個月且病情可能隨時間惡化的疾病。注射給藥裝置用於長期給藥，預計未來幾年市場規模將穩定成長。到2030年，該市場規模預計將達到795.1億美元，複合年成長率（CAGR）為7.9%。預測期內的成長可歸因於以下因素：患者擴大使用自我給藥裝置、對個人化給藥的需求不斷成長、生物製藥製劑研發管線不斷擴展、對智慧注射技術的投資增加以及居家醫療解決方案的日益普及。預測期內的主要趨勢包括：預填充式注射器和安全注射器的日益普及、自動注射器和注射筆需求的成長、家庭注射療法的日益廣泛應用、穿戴式和植入式輸液泵的廣泛應用，以及對劑量準確性和患者安全的日益重視。

慢性病盛行率的上升預計將推動注射給藥裝置市場的成長。慢性病是指持續超過三個月且病情可能隨時間惡化的疾病。注射給藥裝置為長期用藥提供了可靠且方便的方法。這些裝置有助於患者堅持處方治療方案，確保有效控制慢性病，並最終改善健康。例如，總部位於瑞士的國際組織－世界衛生組織（WHO）於2024年2月預測，2050年，全球新增癌症病例將超過3,500萬例，比2022年估計的2,000萬例增加77%。因此，慢性病盛行率的上升將推動注射給藥裝置市場未來的成長。

注射給藥裝置市場的主要企業正致力於開發先進的解決方案，包括穿戴式式和智慧注射器，以提高患者的便利性、改善用藥依從性並支持複雜治療方法的自我給藥。穿戴式和智慧注射器是創新系統，旨在精準輸送藥物劑量，包括生物製藥和大劑量製劑，同時減少不適感、最大限度地減少使用者操作錯誤並改善整體治療體驗。例如，2025年1月，總部位於美國的醫療科技公司貝克頓·迪金森公司（BD）發布了多款新一代設備，包括BD Accuspray鼻噴系統、BD Hylok玻璃預充式注射器、BD Effivax玻璃預填充式注射器、BD Libertas穿戴式式注射器、BD Evolve體表筆注射器、BD Phys Phys型一次性注射器、BD Libertas穿戴式式注射器、BD Evolve體表筆注射器、BD Phys Phys型一次性注射器、BD Libertas穿戴式式注射器、BD Evolve體表筆注射器、BD Phys Physioject一次性注射器。這些解決方案採用人性化設計，方便患者自行給藥；可實現生物製藥和疫苗的精準穩定給藥；兼容多種藥物製劑；採用穿戴式式設計，方便大劑量給藥；並透過一次性組件確保無菌性和安全性。此次產品發布凸顯了業界向以患者為中心的先進注射給藥系統轉型，旨在提高患者依從性、舒適度並改善治療效果。

關鍵技術和未來趨勢
- 人工智慧和自主智慧
- 生物技術、基因組學和精準醫學
- 數位化、雲端運算、巨量資料、網路安全
- 物聯網 (IoT)、智慧基礎設施和互聯生態系統
- 工業4.0和智慧製造
主要趨勢
- 預填充式注射器注射器和安全注射器的使用率不斷提高
- 對自動注射器和筆式注射器的需求不斷成長
- 擴大家庭注射療法的使用範圍
- 穿戴式和植入式輸液幫浦的興起
- 更重視劑量準確性與病人安全

第5章終端用戶產業市場分析

醫院和診所
居家醫療保健服務提供者
製藥公司
生技公司
研究所

第6章市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章全球策略分析架構、目前市場規模、市場對比及成長率分析

全球注射給藥裝置市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
全球注射式藥物輸送裝置市場規模、對比及成長率分析
全球注射給藥裝置市場表現：規模與成長，2020-2025年
全球注射給藥裝置市場預測：規模與成長，2025-2030年，2035年預測

第8章全球潛在市場總量（TAM）

第9章市場細分

按類型
注射器、注射器、幫浦
透過使用
自體免疫疾病、內分泌疾病、腫瘤學、罕見疾病、疼痛管理、呼吸系統治療及其他應用
最終用戶
醫院和診所、居家醫療機構、製藥和生物技術公司、研究實驗室以及其他最終用戶
按類型細分：注射器
普通注射器、預填充式注射器、安全針筒
按類型細分：噴油器
自動注射器、筆式注射器、無針注射器
按類型細分：泵
胰島素幫浦、攜帶式輸液幫浦、植入式幫浦

第10章區域與國家分析

全球注射給藥裝置市場：區域分析、預測及成長，2020-2025年、2025-2030年預測、2035年預測
全球注射給藥裝置市場：依國家分類，實際結果及預測，2020-2025年、2025-2030年預測、2035年預測

第11章亞太市場

第12章：中國市場

第13章印度市場

第14章日本市場

第15章：澳洲市場

第16章印尼市場

第17章韓國市場

第18章台灣市場

第19章東南亞市場

第20章：西歐市場

第21章英國市場

第22章德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章東歐市場

第27章：俄羅斯市場

第28章北美市場

第29章：美國市場

第30章：加拿大市場

第31章南美洲市場

第32章：巴西市場

第33章中東市場

第34章：非洲市場

第35章市場監理與投資環境

第36章：競爭格局與公司概況

注射式藥物輸送裝置市場：競爭格局及市場佔有率（2024年）
注射式藥物輸送裝置市場：公司估值矩陣
注射式藥物輸送裝置市場：公司概況
- Becton, Dickinson and Company
- Baxter International
- Gerresheimer AG
- Catalent, Inc.
- Antares Pharma

第37章：其他領先和創新企業

Owen Mumford, West Pharmaceutical Services, Inc., B. Braun Melsungen AG, Ypsomed AG, AptarGroup, Inc., Nemera, Teleflex Medical, Medtronic, Caplin Steriles Limited, Hovione Technology, Jiangsu Delfu Medical Device Co., Ltd., Terumo Corporation, Roche, Sorrel Medical, Novo Nordisk

第38章全球市場競爭基準分析與儀錶板

第39章重大併購

第40章：高潛力市場國家、細分市場與策略

2030年注射給藥裝置市場：提供新機會的國家
2030年注射給藥裝置市場：充滿新機會的細分市場
2030年注射給藥裝置市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第41章附錄

簡介目錄

Product Code: ME3MIDDD01_G26Q1

Injectable Drug Delivery Devices are medical devices specifically designed to deliver medications directly into the body via injections. These devices are utilized for multiple routes of drug administration, including intravenous, subcutaneous, intradermal, intraperitoneal, and intramuscular.

The primary types of injectable drug delivery devices include conventional injectables, pre-filled syringes, auto-injectors, and pen injectors. Pre-filled syringes come with a fixed needle and contain single-dose vaccines or other medications. These devices find applications in various medical areas such as autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. Injectable drug delivery devices are utilized by a range of end-users, including hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, and others.

Tariffs are impacting the injectable drug delivery devices market by increasing costs of imported medical-grade plastics, stainless steel components, micro-needles, electronic sensors, and precision manufacturing equipment. Hospitals, pharmaceutical companies, and device manufacturers in North America and Europe are most affected due to reliance on global component sourcing, while Asia-Pacific faces cost pressure on export-oriented production. These tariffs are raising device manufacturing costs and affecting pricing strategies. However, they are also encouraging localized production, regional supplier diversification, and investments in domestic medical device manufacturing infrastructure.

The injectable drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides injectable drug delivery devices market statistics, including injectable drug delivery devices industry global market size, regional shares, competitors with a injectable drug delivery devices market share, detailed injectable drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the injectable drug delivery devices industry. This injectable drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The injectable drug delivery devices market size has grown strongly in recent years. It will grow from $54.3 billion in 2025 to $58.69 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, expansion of biologics and biosimilars, increasing hospital-based injectable treatments, improvements in sterile manufacturing practices, wider availability of injection devices.

The injectable drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $79.51 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing shift toward self-administration devices, rising demand for personalized drug delivery, expansion of biologic drug pipelines, growing investments in smart injection technologies, increasing adoption of home healthcare solutions. Major trends in the forecast period include increasing adoption of prefilled and safety syringes, rising demand for autoinjectors and pen injectors, growing use of home-based injectable therapies, expansion of wearable and implantable infusion pumps, enhanced focus on dose accuracy and patient safety.

The rising prevalence of chronic diseases is expected to propel the growth of the injectable drug delivery devices market. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Injectable drug delivery devices offer a reliable and convenient method for the administration of medications over extended periods. These devices can enhance patient adherence to prescribed treatment regimens, ensuring the effective management of chronic conditions and ultimately leading to better health outcomes. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, there would be over 35 million new cancer cases, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising prevalence of chronic diseases is driving the growth of the injectable drug delivery devices market going forward.

Major companies in the injectable drug delivery devices market are focusing on developing advanced solutions, including wearable and smart injectors, to enhance patient convenience, improve adherence, and support self-administration of complex therapies. Wearable and smart injectors are innovative systems designed to deliver accurate doses of medications, including biologics and large-volume formulations, while reducing discomfort, minimizing user error, and improving the overall treatment experience. For example, in January 2025, Becton, Dickinson and Company, a US-based medical technology company, launched several next-generation devices, including the BD Accuspray Nasal Spray System, BD Hylok Glass Prefillable Syringe, BD Effivax Glass Prefillable Syringe, BD Libertas Wearable Injector, BD Evolve On-body Injector, BD Physioject Disposable Autoinjector, and BD Vystra Disposable Pen. These solutions feature user-friendly designs for self-administration, precise and consistent dosing for biologics and vaccines, compatibility with diverse drug formulations, and wearable formats for large-volume delivery, while ensuring sterility and safety through disposable components. The launch highlights the industry's shift toward advanced, patient-centric injectable drug delivery systems aimed at improving adherence, comfort, and therapeutic outcomes.

In May 2025, Amneal Pharmaceuticals, Inc., a US-based provider of generic, specialty, and biosimilar pharmaceutical products, entered a strategic collaboration with Apiject Systems, Corp. to advance resilient, high-volume sterile manufacturing in the U.S. using innovative blow-fill-seal (BFS) injectable solutions. The partnership aims to increase production of sterile drug products by combining Amneal's manufacturing capabilities with Apiject's advanced BFS technology, strengthening the supply chain, expanding output, and enhancing the ability to produce injectables, ophthalmic treatments, and inhalation therapies. Apiject Systems, Corp. is a US-based medical technology company specializing in advanced drug delivery systems, including BFS-based injectable platforms.

Major companies operating in the injectable drug delivery devices market are Becton Dickinson and Company, Baxter International, Gerresheimer AG, Catalent Inc., Antares Pharma, Owen Mumford, West Pharmaceutical Services Inc., B. Braun Melsungen AG, Ypsomed AG, AptarGroup Inc., Nemera, Teleflex Medical, Medtronic, Caplin Steriles Limited, Hovione Technology, Jiangsu Delfu Medical Device Co. Ltd., Terumo Corporation, Roche, Sorrel Medical, Novo Nordisk

North America was the largest region in the injectable drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the injectable drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Injectable Drug Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses injectable drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for injectable drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injectable drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Type: Syringes; Injectors; Pump
2) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
3) By End-user: Hospitals And Clinics; Home Healthcare Settings; Pharmaceutical And Biotechnological Companies; Research Laboratories; Other End Users
Subsegments:
1) By Syringes: Conventional Syringes; Prefilled Syringes; Safety Syringes
2) By Injectors: Autoinjectors; Pen Injectors; Needle-Free Injectors
3) By Pumps: Insulin Pumps; Ambulatory Infusion Pumps; Implantable Pumps
Companies Mentioned: Becton Dickinson and Company; Baxter International; Gerresheimer AG; Catalent Inc.; Antares Pharma; Owen Mumford; West Pharmaceutical Services Inc.; B. Braun Melsungen AG; Ypsomed AG; AptarGroup Inc.; Nemera; Teleflex Medical; Medtronic; Caplin Steriles Limited; Hovione Technology; Jiangsu Delfu Medical Device Co. Ltd.; Terumo Corporation; Roche; Sorrel Medical; Novo Nordisk
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Injectable Drug Delivery Devices Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Injectable Drug Delivery Devices Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Injectable Drug Delivery Devices Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Injectable Drug Delivery Devices Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Artificial Intelligence And Autonomous Intelligence
- 4.1.2 Biotechnology, Genomics And Precision Medicine
- 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
- 4.1.4 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
- 4.1.5 Industry 4.0 And Intelligent Manufacturing
4.2. Major Trends
- 4.2.1 Increasing Adoption Of Prefilled And Safety Syringes
- 4.2.2 Rising Demand For Autoinjectors And Pen Injectors
- 4.2.3 Growing Use Of Home-Based Injectable Therapies
- 4.2.4 Expansion Of Wearable And Implantable Infusion Pumps
- 4.2.5 Enhanced Focus On Dose Accuracy And Patient Safety

5. Injectable Drug Delivery Devices Market Analysis Of End Use Industries

5.1 Hospitals And Clinics
5.2 Home Healthcare Providers
5.3 Pharmaceutical Companies
5.4 Biotechnology Companies
5.5 Research Laboratories

6. Injectable Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Injectable Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Injectable Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Injectable Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis
7.3. Global Injectable Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Injectable Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Injectable Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Injectable Drug Delivery Devices Market Segmentation

9.1. Global Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Syringes, Injectors, Pump
9.2. Global Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
9.3. Global Injectable Drug Delivery Devices Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
9.4. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Syringes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Conventional Syringes, Prefilled Syringes, Safety Syringes
9.5. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Injectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Autoinjectors, Pen Injectors, Needle-Free Injectors
9.6. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps

10. Injectable Drug Delivery Devices Market Regional And Country Analysis

10.1. Global Injectable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Injectable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Injectable Drug Delivery Devices Market

11.1. Asia-Pacific Injectable Drug Delivery Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Injectable Drug Delivery Devices Market

12.1. China Injectable Drug Delivery Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Injectable Drug Delivery Devices Market

13.1. India Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Injectable Drug Delivery Devices Market

14.1. Japan Injectable Drug Delivery Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Injectable Drug Delivery Devices Market

15.1. Australia Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Injectable Drug Delivery Devices Market

16.1. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Injectable Drug Delivery Devices Market

17.1. South Korea Injectable Drug Delivery Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Injectable Drug Delivery Devices Market

18.1. Taiwan Injectable Drug Delivery Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Injectable Drug Delivery Devices Market

19.1. South East Asia Injectable Drug Delivery Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Injectable Drug Delivery Devices Market

20.1. Western Europe Injectable Drug Delivery Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Injectable Drug Delivery Devices Market

21.1. UK Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Injectable Drug Delivery Devices Market

22.1. Germany Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Injectable Drug Delivery Devices Market

23.1. France Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Injectable Drug Delivery Devices Market

24.1. Italy Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Injectable Drug Delivery Devices Market

25.1. Spain Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Injectable Drug Delivery Devices Market

26.1. Eastern Europe Injectable Drug Delivery Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Injectable Drug Delivery Devices Market

27.1. Russia Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Injectable Drug Delivery Devices Market

28.1. North America Injectable Drug Delivery Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Injectable Drug Delivery Devices Market

29.1. USA Injectable Drug Delivery Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Injectable Drug Delivery Devices Market

30.1. Canada Injectable Drug Delivery Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Injectable Drug Delivery Devices Market

31.1. South America Injectable Drug Delivery Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Injectable Drug Delivery Devices Market

32.1. Brazil Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Injectable Drug Delivery Devices Market

33.1. Middle East Injectable Drug Delivery Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Injectable Drug Delivery Devices Market

34.1. Africa Injectable Drug Delivery Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Injectable Drug Delivery Devices Market Regulatory and Investment Landscape

36. Injectable Drug Delivery Devices Market Competitive Landscape And Company Profiles

36.1. Injectable Drug Delivery Devices Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Injectable Drug Delivery Devices Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Injectable Drug Delivery Devices Market Company Profiles
- 36.3.1. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Baxter International Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Catalent, Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Antares Pharma Overview, Products and Services, Strategy and Financial Analysis

37. Injectable Drug Delivery Devices Market Other Major And Innovative Companies

Owen Mumford, West Pharmaceutical Services, Inc., B. Braun Melsungen AG, Ypsomed AG, AptarGroup, Inc., Nemera, Teleflex Medical, Medtronic, Caplin Steriles Limited, Hovione Technology, Jiangsu Delfu Medical Device Co., Ltd., Terumo Corporation, Roche, Sorrel Medical, Novo Nordisk

38. Global Injectable Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Injectable Drug Delivery Devices Market

40. Injectable Drug Delivery Devices Market High Potential Countries, Segments and Strategies

40.1 Injectable Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
40.2 Injectable Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
40.3 Injectable Drug Delivery Devices Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies